December 17, 2022
Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, according to a new model created by Weill Cornell Medicine, NewYork-Presbyterian and University of Oxford investigators.
December 15, 2022
An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators. Mesenchymal colorectal cancer (mCRC) accounts for about one-third of all colorectal cancers. Targeted immune therapies aren't effective against this form of cancer because the environment inside the tumor keeps immune cells that would kill the tumor cells at bay. But a team led by Dr. Maria Diaz-Meco and Dr. Jorge Moscat, who are both Homer T. Hirst III Professors of Oncology in Pathology at Weill...
December 13, 2022
The long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals compared with non-pregnant individuals of reproductive age, according to a study by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The similarity in protection is noteworthy, given that pregnancy alters the immune system, and potentially the response to vaccination.
December 6, 2022
Congratulations to Drs. Amy Chadburn and Cynthia Magro on being recipients of the Exceptional Women in Medicine by Castle Connolly 2022!
November 22, 2022
A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell Medicine researchers.
November 21, 2022
Please join us in congratulating Dr. Melissa Cushing for her appointment as the Daniel M. Knowles, M.D. Distinguished Professor in Pathology and Laboratory Medicine.
October 14, 2022
Dr. Liming Bao became the Weill Cornell Medicine and NYP/WC Director of Cytogenetics on October 1, 2022. Dr. Bao joins us from the University of Colorado Anschutz Medical Campus where he is a professor of pathology at the Colorado University School of Medicine. He is board-certificated in clinical cytogenetics and molecular genetics by the American Board of Medical Genetics and Genomics.
October 14, 2022
Dr. Benjamin Kleaveland, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded a five-year, $2.1 million grant from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health to investigate how cells regulate noncoding RNAs, molecules that are thought to have major roles in health and disease.
September 22, 2022
A common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may promote these diseases by altering the stem cells’ programming of gene activity and the mix of blood cells they produce, according to a study co-led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, the
August 15, 2022
A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine has been deployed in clinical tests in Uganda to identify cases of Kaposi sarcoma, a common yet difficult-to-detect cancer that often signals the presence of HIV infection. Ethel Cesarman, MD, PhDProfessor of Pathology and Laboratory MedicineNow, thanks to a $4 million grant from the National Cancer Institute Center for Global Health, the rollout is expanding to 11 sites throughout sub-Saharan Africa, including locations in Kenya, Tanzania, Rwanda, Botswana and Malawi – where a shortage of...